Paediatric population

The pooled clinical safety database for Voraxaze® includes data for 232 patients up to 17 years of age.


within the central MTX HPLC population


This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Abbreviations: CIR, clinically important reduction;HPLC, high-performance liquid chromatography; MTX, methotrexate.